Perrigo Company Faces Class Action Lawsuit for Misleading Statements
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 14 2026
0mins
Source: PRnewswire
- Class Action Reminder: The Schall Law Firm alerts investors of a class action lawsuit against Perrigo Company for violations of securities laws related to securities transactions between February 27, 2025, and November 4, 2025, urging investors to contact them before January 16, 2026, to participate.
- False Statement Allegations: The complaint alleges that Perrigo failed to disclose serious underinvestment in repairs and operational optimization of the baby formula business acquired from Nestlé, leading to significant losses for investors.
- Market Reaction: When the market learned the truth about Perrigo, investors suffered damages, indicating that the company's public statements were false and materially misleading throughout the class period, impacting investor decisions.
- Legal Consultation Opportunity: The Schall Law Firm offers free consultations and encourages affected investors to reach out to discuss their rights, demonstrating the firm's commitment to protecting shareholder interests.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PRGO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PRGO
Wall Street analysts forecast PRGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRGO is 20.33 USD with a low forecast of 18.00 USD and a high forecast of 23.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 14.000
Low
18.00
Averages
20.33
High
23.00
Current: 14.000
Low
18.00
Averages
20.33
High
23.00
About PRGO
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Perrigo Company Faces Class Action for Misleading Statements
- Class Action Reminder: The Schall Law Firm alerts investors of a class action lawsuit against Perrigo Company for violations of securities laws, concerning securities purchases made between February 27 and November 4, 2025, with a deadline to contact the firm by January 16, 2026.
- False Statement Allegations: The complaint alleges that Perrigo failed to adequately invest in repairs and operational optimization for the baby formula business acquired from Nestlé, leading to materially misleading public statements that misrepresented cost estimates to investors.
- Market Reaction: As the market became aware of Perrigo's actual situation, investor losses significantly increased, highlighting the company's major failures in information disclosure, which could adversely affect its future stock performance.
- Legal Consultation Opportunity: The Schall Law Firm offers free consultations and encourages affected investors to reach out to understand their rights, emphasizing the firm's focus on securities class actions aimed at helping investors recover losses.
Continue Reading
Perrigo Company Faces Class Action Lawsuit for Misleading Statements
- Class Action Reminder: DJS Law Group alerts investors of a class action lawsuit against Perrigo Company for violations of securities laws during the trading period from February 27, 2025, to November 4, 2025, encouraging affected shareholders to contact the firm for potential claims.
- Misleading Statements Exposed: The complaint alleges that Perrigo made false and misleading statements following its acquisition of Nestlé's baby formula business, revealing significant underinvestment in maintenance that forced the company to make substantial remedial investments, thus misleading investors throughout the class period.
- Investor Losses: Shareholders who suffered losses are urged to reach out to DJS Law Group to participate in potential recovery, indicating that the company's mismanagement post-acquisition has adversely affected shareholder returns.
- Commitment to Legal Services: DJS Law Group specializes in securities class actions and corporate governance litigation, emphasizing its dedication to enhancing investor returns through balanced counseling and aggressive advocacy, showcasing its expertise and commitment to client interests.
Continue Reading